Science Explorer Back to mapMap
Discussion
Researcher · UCB Pharma (United Kingdom) · United Kingdom

Mark Bodmer

Mark Bodmer publishes mostly in Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging, on topics such as Monoclonal and Polyclonal Antibodies Research, Gut microbiota and health and Immune Response and Inflammation.

OpenAlex
World rank
#390,330
of 7,710,434 ranked researchers
Rank in United Kingdom
#34,436
of 367,258
Works
48
Citations
2.8k
Citations per work
57.8
h-index
24
i10-index 28Top 24% in Molecular Biology
Mark Bodmer

What does Mark Bodmer research?

Mark Bodmer's work is mostly in Medicine (28%), Biochemistry, Genetics and Molecular Biology (20%), Immunology and Microbiology (17%).

Life Sciences: 18 works · 37.8% of their workBiochemistry, Genetics and Molecular Biology: 10 works · 20.5% of their workMolecular Biology: 10 works · 20.5% of their workImmunology and Microbiology: 8 works · 17.3% of their workImmunology: 8 works · 17.3% of their workEverything else: 17 works · 34.7% of their workHealth Sciences: 13 works · 27.5% of their workMedicine: 13 works · 27.5% of their workRadiology, Nuclear Medicine and Imaging: 5 works · 11.0% of their workOncology: 4 works · 7.9% of their workEpidemiology: 2 works · 4.7% of their workImmunology and Allergy: 2 works · 3.9% of their workTHEIR WORKMark Bodmer48works
Life Sciences38%Health Sciences28%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1020.5%
    2. Immunology and Microbiology817.3%
  2. Everything else1734.7%
    1. Medicine1327.5%
  1. 1Molecular Biology20% of their works
  2. 2Immunology17% of their works
  3. 3Radiology, Nuclear Medicine and Imaging11% of their works
  4. 4Oncology8% of their works
  5. 5Epidemiology5% of their works
  6. 6Immunology and Allergy4% of their works

Research topics

Which keywords describe Mark Bodmer's research?

The keywords of their largest research topics: Fc Receptors, Therapeutic Antibodies, Gut Microbiota, Microbial Communities, Pattern Recognition Receptors, Toll-like Receptors, Sepsis and Septic Shock.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. Fc Receptors111 topic
  2. Therapeutic Antibodies111 topic
  3. Gut Microbiota81 topic
  4. Microbial Communities81 topic
  5. Pattern Recognition Receptors71 topic
  6. Toll-like Receptors71 topic
  7. Sepsis61 topic
  8. Septic Shock61 topic
  9. Filaggrin41 topic
  10. Foxp341 topic
  11. Immune Checkpoint Blockade41 topic
  12. PD-1 and PD-L141 topic
  13. Skin Microbiome41 topic
  14. TGF-ß41 topic
  15. Bacterial Therapy31 topic
  16. Tumor Targeting31 topic

Where does Mark Bodmer work?

Mark Bodmer's main affiliation in the publication record is UCB Pharma (United Kingdom), United Kingdom.

How many publications and citations does Mark Bodmer have?

OpenAlex counts 48 works and 2,776 citations for Mark Bodmer, an h-index of 24, ranking #390,330 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mark Bodmer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.